Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cavco Industries (CVCO) Cash & Equivalents (2016 - 2025)

Cavco Industries (CVCO) has disclosed Cash & Equivalents for 16 consecutive years, with $224.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 1379.88% to $224.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $224.6 million, a 1379.88% increase, with the full-year FY2025 number at $18.5 million, up 19.73% from a year prior.
  • Cash & Equivalents was $224.6 million for Q4 2025 at Cavco Industries, down from $375.0 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $377.3 million in Q3 2023 to a low of $9.9 million in Q4 2022.
  • A 5-year average of $185.0 million and a median of $231.3 million in 2022 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: plummeted 96.29% in 2022, then soared 1379.88% in 2025.
  • Cavco Industries' Cash & Equivalents stood at $224.3 million in 2021, then tumbled by 95.58% to $9.9 million in 2022, then skyrocketed by 33.34% to $13.2 million in 2023, then grew by 14.85% to $15.2 million in 2024, then skyrocketed by 1379.88% to $224.6 million in 2025.
  • Per Business Quant, the three most recent readings for CVCO's Cash & Equivalents are $224.6 million (Q4 2025), $375.0 million (Q3 2025), and $23.2 million (Q2 2025).